Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2003
12/04/2003WO2002070708A3 Glutamate receptor modulatory proteins and nucleic acids encoding them
12/04/2003WO2002069840A3 Nucleic acids for transforming fish cells and methods for their use
12/04/2003WO2002068635A3 Methods of inhibiting expression of a target gene in mammalian cells
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002062943A3 Use of oligonucleotides for improving plasmid transfection in cells, transfection method and kit
12/04/2003WO2002062839A3 Markers of unstable atherosclerotic plaques
12/04/2003WO2002057427A3 Mammalian tumor susceptibility gene products and their uses
12/04/2003WO2002043774A3 Compositions and therapeutical use of polynucleotides encoding tcrs
12/04/2003WO2002038810A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2002036806A9 Expression vectors able to elicit improved immune response and methods of using same
12/04/2003WO2002030462A3 Hedgehog antagonists, methods and uses related thereto
12/04/2003WO2002024947A3 Cancer associated protein kinases and their uses
12/04/2003WO2001072771A3 Insulin and igf-1 receptor agonists and antagonists
12/04/2003WO2001050829A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor
12/04/2003WO1999013818A3 Membrane virus host range mutations and their uses as vaccine substrates
12/04/2003US20030226178 Maize CLAVATA3-like polynucleotide sequences and methods of use
12/04/2003US20030226177 Dwarfism genes and dwarf plants
12/04/2003US20030226175 Comprises nucleotide sequences coding polypeptides which control fruit ripening in bananas; bioreactors for expressing heterologous therapeutic proteins
12/04/2003US20030226174 Invention provides transgenic tomato that over-expresses ANT1 and that produces glycitein flavonoid
12/04/2003US20030226173 Transgenic plants expressing heterologous nuclelotide sequences which confer improvement in preferred phenotypic characteristics such as crop yield and/or vigor
12/04/2003US20030226172 Preparing and recovering transgenic and disease resistant grapevines; biological pest control; immunoassay
12/04/2003US20030226171 Insect resistant plants and methods for making same
12/04/2003US20030226170 Transgenic plant comprising vector coding p.parasitica protein (PPR1) protein for propagating disease resistant plants; biological pest control
12/04/2003US20030226169 DNA sequences encoding antifungal proteins
12/04/2003US20030226168 Plant preparations
12/04/2003US20030226167 Comprises nucleotide sequences coding maize non-apical meristem protein (ZMNAM) for improving endosperm, kernal size and plant vigor
12/04/2003US20030226166 Comprises expression vector coding regulatory sequences for efficient expression of heterologous polypeptides which confer herbicide, disease and insect resistance in plants; improved stability or shelf life
12/04/2003US20030226164 Using recombinase to obtain site-specific recombination of DNA within dicotyledonous and monocotyledonous plant cells
12/04/2003US20030226163 Preparing trangenic cells which comprise 3-hydroxy-3-methylglutaryl CoA reductase regulatory sequences for use in expression of heterologous polypeptides; biological pest control; bioreactors
12/04/2003US20030226162 Genetically engineered woody plants with enhanced glucosyltransferase activity; papermaking
12/04/2003US20030226161 Salutaridinol 7-O-acetyltransferase and derivatives thereof
12/04/2003US20030226160 Compositions and methods for locating preferred integration sites within the genome of a plant
12/04/2003US20030226159 Preparation of transgenic animal model for monitoring tumor development and treatments using stem cells
12/04/2003US20030226158 Cds1 knockout cells and mice, and their utilization
12/04/2003US20030226155 Modified transferrin-antibody fusion proteins
12/04/2003US20030225528 Gene expression profiling in biopsied tumor tissues
12/04/2003US20030225260 Production of recombinant AAV virions
12/04/2003US20030225259 Novel human kinase and polynucleotides encoding the same
12/04/2003US20030225258 Novel human proteases and polynucleotides encoding the same
12/04/2003US20030225257 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
12/04/2003US20030225253 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/04/2003US20030225252 PNA monomer and precursor
12/04/2003US20030225250 Intestinal trefoil proteins
12/04/2003US20030225247 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
12/04/2003US20030225117 Use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes
12/04/2003US20030225025 MDA-7 proteins and methods of use thereof
12/04/2003US20030225021 Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
12/04/2003US20030225019 Notch1 inhibitors for inducing apoptosis
12/04/2003US20030225018 Modulating angiogenesis in an animal by modulating the expression or activity of syndecan-2.
12/04/2003US20030225017 Chlamydia antigens and corresponding DNA fragments and uses thereof
12/04/2003US20030225015 Treating developmental disorders, aberrant apoptosis, and hyperproliferative disorders such as cancer
12/04/2003US20030225014 Antisense modulation of PLML expression
12/04/2003US20030225013 Oligonucleotide that specifically hybridizes with a nucleic acid encoding phosphoinositide-3-kinase, regulatory subunit 4, p150 and inhibits its expression; treating hyperproliferative and metabolic disorders
12/04/2003US20030225012 Antisense modulation of transcription factor DP-1 expression
12/04/2003US20030225006 Novel spinosyn-producing polyketide synthases
12/04/2003US20030224987 Binding to formyl peptide receptor or formyl peptide receptor-like 1
12/04/2003US20030224985 Enhanced resistance to TS-inhibiting drugs like 5-fluorouracil or 5-fluoro-2-deoxyuridinemonophosphate.
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224968 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin
12/04/2003US20030224522 Methods for delivering nucleic acid molecules into cells and assessment thereof
12/04/2003US20030224521 Using artificial bacterial chromosome and homologous recombination as tools for stable transfer of genetic material into cells; gene replacement; transgenic animal models
12/04/2003US20030224519 Using chemical and insertional mutagenesis to determine genic function
12/04/2003US20030224517 Comprises oligonucleotides which inhibit secretase activity on amyloid precursor proteins (APP) for treating alzheimer's and neurodegenerative diseases
12/04/2003US20030224516 Comprises oligonucleotides for controlling expression of prospero- related homeobox 1 (PROX-1) and treatment of metabolic and vision disorders
12/04/2003US20030224515 Comprises oligonucleotides for controlling expression of regulatory protein and treatment of metabolic, diabetic, atherosclerotic, cardiovascular and hyperlipidemic
12/04/2003US20030224514 Antisense modulation of PPAR-delta expression
12/04/2003US20030224513 Antisense modulation of Notch1 expression
12/04/2003US20030224512 Antisense modulation of beta-site APP-cleaving enzyme expression
12/04/2003US20030224511 Oligonucleotide for preventing cysteine protease expression (CAPTHESIN Z) and treatment of viral, infectious and tumor diseases
12/04/2003US20030224508 Novel vectors and genes exhibiting increased expression
12/04/2003US20030224500 Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereof
12/04/2003US20030224498 Comprises nucleotide sequences coding serpin domains for diagnosis and treatment of metabolic and infectious disorders; enzyme inhibitors; cosmetic or nutriceutical; drug screening
12/04/2003US20030224495 Synthesis performed in enantiomer-pure form with chorismate by cultivation of genetically altered non-pathogenic organism which has aromate embolism and increased activity of isochorismate synthase and isochorismatase
12/04/2003US20030224494 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
12/04/2003US20030224492 Introducing one or more specific mutations into a selected DNA sequences; genetic engineering
12/04/2003US20030224491 Continuous fermentation process
12/04/2003US20030224489 Plasmid for transformation and expression of chymosin nucleotide sequences in aspergillus
12/04/2003US20030224488 Materials and methods for preparing dimeric growth factors
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224484 Plasmid for transferring genetic information into prokaryotic gene sequences/operons using directed homologous recombination
12/04/2003US20030224483 Control of gene expression in eukaryotic cells
12/04/2003US20030224482 Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
12/04/2003US20030224481 In vivo gene transfer
12/04/2003US20030224480 Method of designing multifunctional base sequence
12/04/2003US20030224479 Suppressor tRNA system
12/04/2003US20030224477 Comprises nucleotide sequences associated with expression vectors for improving gene transfer and expression in cells
12/04/2003US20030224463 Using aberrant nucleotide sequence repair to diagnose and determine cancer predisposition
12/04/2003US20030224458 Novel human G-protein coupled receptor, HGPRBMY23, expressed highly in kidney
12/04/2003US20030224448 Methods for structural analysis of proteins
12/04/2003US20030224444 Antibodies to native conformations of membrane proteins
12/04/2003US20030224440 Vomeronasal organ nucleotide sequences for use in diagnosis and treatment of sexual disorders
12/04/2003US20030224437 Discriminately identifying nucleic acid sequences of coliform bacteria; high throughput assay
12/04/2003US20030224435 Detection of abused substances and their metabolites using nucleic acid sensor molecules
12/04/2003US20030224434 Homogeneous real-time mutation scanning using denaturation/renaturation kinetics; restriction fragment length polymorphisms
12/04/2003US20030224432 Preparing small interfering RNAs for use as tools in determining gene function
12/04/2003US20030224430 Regulation of human eosinophil serine protease 1-like enzyme
12/04/2003US20030224416 Diagnosing psychological disorders via detection of transcriptional variants in gene coding membrane proteins associated electrical potential; drug screening
12/04/2003US20030224415 Selection free growth of host cells containing multiple integrating vectors
12/04/2003US20030224414 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders
12/04/2003US20030224413 Comprises polynucleotides coding restriction fragment length polymorphism for use in identifying, characterizing and treatment of blood, respiratory, tumor and nervous system disorders
1 ... 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 ... 4023